88IV - PR Newswire Asia's news


TCI Biotech Returns to Vitafoods Europe 2026 with Five Provocations for the Nutraceutical Industry and a Glimpse of the Future BARCELONA, Spain , April 14, 2026 /PRNewswire/ -- TCI Biotech, the global CDMO+ leader in health and wellness innovation, will return to Vitafoods Europe 2026 at booth 3F40, Fira Barcelona Gran ... 2026-04-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Phrontline Biopharma Presents Preclinical Data for TJ106, a Biparatopic HER2 Dual-Payload ADC, at American Association for Cancer Research Annual Meeting 2026 Data Demonstrate Activity in HER2-Low and ADC-Resistant Tumor Models, Supporting Advancement Toward IND ... 2026-04-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Clarity signs a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with Nucleus RadioPharma SYDNEY , April 14, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation ... 2026-04-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report Advancing Climate Action, Governance Excellence, and Global Scientific Impact ... 2026-04-14T Biotechnology Health Care/Hospital
Origin Agritech Launches Redesigned Corporate Website to Better Serve Partners, Customers, and Investors Delivering an Enhanced Digital Experience Showcasing the Company's Agricultural Biotechnology Leadership, Product Portfolio, and Investor Resources ... 2026-04-14T Agriculture Biotechnology
Telix Refinances Convertible Bonds MELBOURNE, Australia and INDIANAPOLIS, Ind. , April 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX) (" Telix ") today launches an offering of US$550 million convertible ... 2026-04-14T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Senhwa Biosciences Secures Strategic Backing from Global Investor GEM with Up to NT$500 Million to Accelerate AI-Driven Drug Development TAIPEI and SAN DIEGO , April 14, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company announced today the signing of a Memorandum of Understanding (MOU) ... 2026-04-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Second International Symposium on Yeast Protein Science and Technology Concludes in Yichang SHANGHAI , April 14, 2026 /PRNewswire/ -- The 2nd International Symposium on Yeast Protein Science and Technology, co-hosted by Angel Yeast (SH600298), was held on April 11, 2026 in Yichang, drawing ... 2026-04-14T Biotechnology Computer/Electronics Food/Beverages Health Care/Hospital
Kelun-Biotech Announces Results from the SKB264-II-06/MK-2870-002 Study of Sacituzumab Tirumotecan (Sac-TMT) in Gynecologic Oncology Presented at 2026 SGO CHENGDU, China , April 14, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that results from both ... 2026-04-14T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Caliway's Fat Reduction Drug CBL-514 Phase 2 Clinical Results Accepted by ASJ. CBL-0204's Demonstrated Efficacy and Safety Gain Further Academic Recognition Clinical results from Caliway's CBL-0204 Phase 2b study of its fat reduction drug candidate CBL-514 for localized fat reduction have been accepted by the Aesthetic Surgery Journal (ASJ), a leading academic ... 2026-04-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology